Mutual Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Mutual Advisors, LLC

$3.5 Billion
Q3 2024

A detailed history of Mutual Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Mutual Advisors, LLC holds 1,175 shares of REGN stock, worth $824,673. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,175

Previous 963 22.01%

Holding current value

$824,673

Previous $1.01 Million 22.04%

% of portfolio

0.04%

Previous 0.03%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$1024.09 - $1201.76 $217,107 - $254,773	212 Added 22.01%	1,175 $1.24 Million
Q2 2024 Jul 30, 2024	BUY	$883.2 - $1071.19 $6,182 - $7,498	7 Added 0.73%	963 $1.01 Million
Q1 2024 May 02, 2024	SELL	$902.69 - $993.35 $667,087 - $734,085	-739 Reduced 43.6%	956 $920,000
Q4 2023 Jan 12, 2024	SELL	$775.18 - $881.7 $278,289 - $316,530	-359 Reduced 17.48%	1,695 $1.49 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $860,022 - $1.05 Million	1,242 Added 152.96%	2,054 $1.69 Million
Q2 2023 Jul 31, 2023	SELL	$700.03 - $830.35 $36,401 - $43,178	-52 Reduced 6.02%	812 $583,000
Q1 2023 Apr 11, 2023	BUY	$680.49 - $826.97 $46,273 - $56,233	68 Added 8.54%	864 $709,000
Q4 2022 Jan 12, 2023	BUY	$705.89 - $766.39 $2,117 - $2,299	3 Added 0.38%	796 $0
Q3 2022 Nov 03, 2022	BUY	$573.97 - $724.32 $47,065 - $59,394	82 Added 11.53%	793 $546,000
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $10,967 - $14,776	20 Added 2.89%	711 $420,000
Q1 2022 May 09, 2022	BUY	$595.12 - $698.43 $4,165 - $4,889	7 Added 1.02%	691 $483,000
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $25,000 - $30,864	46 Added 7.21%	684 $432,000
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $14,350 - $17,024	-25 Reduced 3.77%	638 $386,000
Q2 2021 Aug 12, 2021	BUY	$472.8 - $558.54 $313,466 - $370,312	663 New	663 $370,000
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $612,843 - $740,486	-1,125 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$493.32 - $643.92 $554,985 - $724,410	1,125 New	1,125 $702,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Advisors, LLC with notifications on news.

Account

Mutual Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History